Skip to content
Bio Alps
FIND A HEALTH VALLEY ACTOR
Menu
Search
News
BioAlps news
BioAlps 20 years
Events
About
Mission
Organization
Members and Strategic Partners
BioAlps Awards
Media Center
BioAlps Event Formats
Business
Opportunities
Community
Membership Registration
The BioAlps Community
The Health Valley
Business Enablers
Industrial network
Economic Promotion
International Markets
Innovation Enablers
Industrial Networks and Support Institutions
Technology Transfer Organisations
Incubators and Technoparks
Coaching
Financing
Startups and Success Stories
Research Institutions and Education
Universities and Academic Institutions
Research Centres
Research Networks
Education and Training
COVID-19 Key Players
News
« Back to News Listing
Posts navigation
← EPFL and UNIL discovery : How a mutated gene can lead to different forms of cancer
Progressive signaling changes in the olfactory nerve of Alzheimer’s disease patients →
ADC Therapeutics launches Phase I clinical trial
28.01.2019
Share this article
Facebook
X (Twitter)
Linkedin
The Swiss based startup,
ADC Therapeutics
, has dosed a solid tumor patient in its first Phase I clinical trial.
Read the
SBA’s
full
article
in English
Latest articles
27.05.2026
MindMaze Announces a CHF 8.0 Million Equity Financing with Neuro.io
27.05.2026
A New Humanoid Robotics School in Renens
22.05.2026
Inside TRB Chemedica: a visit to one of Valais’ quiet pharmaceutical powerhouses
22.05.2026
HAYA Therapeutics doses first cohort in Phase 1 trial of a precision therapy for cardiac fibrosis
21.05.2026
Swiss Biotool Startup Bionomous Launches Sortivo
